| Cutting edge: Differential fine-tuning of IL-2–and IL-15–dependent functions by targeting their common IL-2/15Rβ/γc receptor D Meghnem, S Morisseau, M Frutoso, K Trillet, M Maillasson, I Barbieux, ... The Journal of Immunology 198 (12), 4563-4568, 2017 | 28 | 2017 |
| Emergence of NK cell hyporesponsiveness after two IL-15 stimulation cycles M Frutoso, S Morisseau, F Tamzalit, A Quéméner, D Meghnem, I Leray, ... The Journal of Immunology 201 (2), 493-506, 2018 | 24 | 2018 |
| Histamine receptor 2 blockade selectively impacts B and T cells in healthy subjects D Meghnem, SA Oldford, ID Haidl, L Barrett, JS Marshall Scientific Reports 11 (1), 1-10, 2021 | 8 | 2021 |
| Specific interleukin-15 (il-15) antagonist polypeptide and uses thereof for the treatment of inflammatory and auto-immune diseases E Mortier, D Meghnem, S Morisseau, Y Jacques US Patent App. 15/754,664, 2018 | 7 | 2018 |
| Toll‐like receptor 2 activation induces C‐C chemokine receptor 2‐dependent natural killer cell recruitment to the peritoneum ID Haidl, D Meghnem, TB Issekutz, JS Marshall Immunology and Cell Biology, 0 | 6 | |
| Développement de nouveaux antagonistes de l’interleukine-15 D Meghnem Nantes, 2016 | | 2016 |
| Abstract B033: A novel IL-2 and IL-15 antagonist shifting the immune balance towards tolerance: Potential therapeutic applications M Dihia, S Morisseau, K Trillet, M Frutoso, I Barbieux, A Quemener, ... Cancer Immunology Research 4 (11 Supplement), B033-B033, 2016 | | 2016 |
